Newspaper Publication for unaudited financial results 30.09.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Remedium Lifecare Limited (Scrip Code 539561) has submitted to BSE copies of a newspaper advertisement containing its unaudited financial results for the quarter and half year ended 30 September 2025, published in Financial Express and Pratatkal on 16 November 2025, as required under SEBI LODR Regulation 30. The covering letter was signed by Whole Time Director Adarsh Munjal (DIN 07304004) and dated 17 November 2025. On a standalone basis, H1 FY26 income fell sharply to Rs 3,368.08 lakhs versus Rs 10,549.03 lakhs in H1 FY25, with the company swinging to a loss of Rs 29.12 lakhs after tax from a profit of Rs 314.80 lakhs. On a consolidated basis, however, H1 FY26 profit after tax came in at Rs 1,327.22 lakhs (EPS Rs 0.15) versus Rs 212.94 lakhs for FY25, indicating stronger performance at the subsidiary level.
This is a routine regulatory compliance disclosure with no new business action. Standalone numbers weakened sharply year-on-year and turned to a loss in H1 FY26, but consolidated profitability rose meaningfully, which may comfort investors relying on group-level earnings.